Anticonvulsant activities of myo-inositol and scyllo-inositol on pentylenetetrazol induced seizures

Seizure

Volumn 20, Issue 2, 2011, Pages 173-176

  Nozadze, M ^b   Mikautadze, E ^a   Lepsveridze, E ^a   Mikeladze, E ^b   Kuchiashvili, N ^b   Kiguradze, T ^b   Kikvidze, M ^a   Solomonia, R ^a,b  

^a ILIA STATE UNIVERSITY   (Georgia)

^b Tbilisi St Andrew the First Called Georgian University of Georgian Patriarchate   (Georgia)

Author keywords

Myo inositol; Pentylenetetrazol; Scyllo inositol; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; INOSITOL; MANNITOL; PENTETRAZOLE; SCYLLO INOSITOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; LATENT PERIOD; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SEIZURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; INOSITOL; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

EID: 79551604692     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.10.008     Document Type: Article

References (24)

1. R.H. Michel Inositol derivatives: evolution and functions Nature Reviews: Molecular Cell Biology 9 2008 151 161
2. K.S. Fisher, J.S. Novak, and B.W. Agranoff Inositol and higher inositol phosphates in neuronal tissues: homeostasis, metabolism and functional significance Journal of Neurochemistry 82 2002 736 754
3. R Solomonia, N. Kuchiashvili, A. Berulava, V. Pkhakadze, N. Trapaidze, and M. Zhvania Purification and identification of components of the Aquilegia vulgaris extract fraction exhibiting anti-epileptic activity Journal of Biological Physics and Chemistry 4 2004 185 192
4. R. Solomonia, M. Nozadze, N. Kuchiashvili, T. Bolkvadze, M. Kiladze, and M. Zhvania Study of effects of myo-Inositol on pentylentetrazol and kainic acid induced convulsions in rats Bulletin of Experimental Biology and Medicine 143 2007 58 60
5. R. Solomonia, E. Mikautadze, M. Nozadze, N. Kuchiashvili, E. Lepsveridze, and T. Kiguradze Myo-Inositol treatment prevents biochemical changes triggered by kainate-induced status epilepticus Neuroscience Letters 468 2010 277 281
6. E.R. Seaquist, and R. Gruetter Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR Magnetic Resonance in Medicine 39 1998 313 316
7. W.R. Sherman, M.A. Stewart, M.M. Kurien, and S.L. Goodwin The measurement of myo-inositol, myo-inositol-2 and scyllo-inositol in mammalian tissues Biochimica et Biophysica Acta 158 1968 197 205
8. W.R. Sherman, M.A. Stewart, P.C. Simpson, and S.L. Goodwin The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues Biochemistry 7 1968 819 824
9. J.A. McLaurin, M.E. Kierstead, M.E. Brown, C.A. Hawkes, M.H.L. Lambermon, and A.L. Phinney Cyclohexanehexol inhibitors of Ab aggregation prevent and reverse Alzheimer phenotype in a mouse model Nature Medicine 6 2006 801 808
10. A.B. Clement, A. Hawkins, A.H. Lichtman, and B.F. Cravatt Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase Journal of Neuroscience 23 2003 3916 3923
11. R.J. Racine Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalography and Clinical Neurophysiology 32 1972 281 294
12. M.J. Berridge, C.P. Downes, and M.R. Hanley Neural and development actions of lithium: a unifying hypothesis Cell 59 1989 411 419
13. G. Agam, Y. Shapiro, Y. Bersudsky, O. Kofman, and R.H. Belmaker High-dose peripheral inositol raises brain inositol levels and reverses behavioural effects of inositol depletion by lithium Pharmacology Biochemistry and Behavior 49 1994 341 343
14. O. Kofman, W.R. Sherman, V. Katz, and R.H. Belmaker Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures Psychopharmacology 110 1993 229 234
15. M.B. Williams, and R.S. Jope Modulation by Inositol of cholinergic-and serotomergic-induces seizures in lithium-treated rats Brain Research 685 1995 169 178
16. J. Levine, M. Gonzalves, I. Barbam, S. Stier, A. Elizur, and O. Kofman Inositol 6 gm daily may be effective in depression, but not in schizophrenia Human Psychopharmacology 8 1993 49 53
17. M.D. Tricklebank, L. Singh, A. Jackson, and R.J. Oles Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain Brain Research 558 1991 145 148
18. D.W. Choi Ionic dependence of glutamate neurotoxicity Journal of Neuroscience 7 1987 369 379
19. S.M. Rothman The neurotoxicity of excitatory amino acid is produced by passive chloride influx Journal of Neuroscience 5 1985 1483 1489
20. P.H. Yancey, M.E. Clark, S.C. Hand, R.D. Bowlus, and G.N. Somero Living with water stress; evolution of osmolyte systems Science 217 1993 1214 1222
21. K. Strange, R. Morrison, C.W. Heilig, S. DiPietro, and S. Gullans Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells The American Journal of Physiology 206 1991 C784 C790
22. J.T. Weise, J.A. Dunlap, C.E. Conner, W.L. Grzybowski, M.A. Lowe, and M.A. Yorek Osmotic regulation of Na+/myo-inositol cotransporter mRNA level and activity in endothelial and neural cells The American Journal of Physiology 270 1996 C990 C997
23. M. Nonaka, E. Kohmura, T. Yamashita, A. Yamauchi, T. Fujinaka, and T. Yoshimine Kainic acid-induces seizure upregulates Na+/myo-inositol cotransporter mRNA in rat brain Molecular Brain Research 70 1999 179 186
24. M.G. Zhvaniia, R.O. Solomoniia, T.Z. Bikashvili, N.T. Kotariia, Chkhikvishvili TsG, and M.T. Kiladze The influence of myo-inositol on the ultrastructure of hippocampal CA1 area in kainate treated rats Tsitologiia 49 2007 939 943